1. From the Department of Urology and UCSF/Mt. Zion Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California, Division of Urology, Cook County Hospital, Chicago and TAP Pharmaceutical Products, Inc., Lake Forest, Illinois, and Department of Urology, University of Washington School of Medicine, Seattle, Washington